Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hart Cunningham Discusses the Benefits of Medical Marijuana
  • USA - English


News provided by

Hart Cunningham 2020 Presidential Election

May 16, 2018, 11:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

CAMBRIDGE, Mass. (PRWEB) May 16, 2018 -- It’s no secret that the healthcare system in the United States is depriving millions of Americans of quality health care. But, access to life-saving drugs is also being prohibited by another institution.

For Americans suffering from cancer, epilepsy, multiple sclerosis, Parkinson’s Disease, and many more ailments, the federal government routinely makes life not just more difficult, but, in many cases, shorter. Affordable, effective drugs are also kept out of reach of Americans with non-life threatening illnesses such as glaucoma and anxiety.

Commonly known as CBD, this non-psychoactive therapy is often mistaken for the recreational element found within cannabis, tetrahydrocannabinol (THC).

Post this

Our Government is Preventing Effective Healthcare

Whether a lack of education or outright prohibition, the federal government’s stance on medical cannabis has prevented millions of Americans from accessing a drug they are desperately in need of: cannabinoids. Commonly known as CBD, this non-psychoactive therapy is often mistaken for the recreational element found within cannabis, tetrahydrocannabinol (THC).

The current US Attorney General Jeff Sessions may be vacillating between “cracking down on marijuana” and not pushing federal prosecutors to begin working “small marijuana cases,” but that does nothing to lift trade prohibiting federal trade regulations, nor recognize CBD as a medicine eligible for health insurance coverage. The government’s long curated cannabis stigma has eroded; more than 3/5 of Americans want the federal government to stop interfering with states’ decisions to legalize cannabis.

Curing Americans with CBD

One incoming 2020 presidential candidate, Hart Cunningham, is strongly motivated to save Americans from the same devastating loss his family experienced. The loss of his father, less than a year after a brain cancer diagnosis, at a time when cultural and legal barriers made it difficult to access CBD treatment, created deep empathy within Cunningham for the millions of Americans with terminal and life-altering illnesses.

For much of his life, Cunningham was a self-described “anti-drug, sports-focused, never a drink in college while taking 8-9 classes per semester to get ahead” type of American. Shortly after entering his thirties, however, shoulder pain led him to CBDs, which he found allowed him to continue focusing on his businesses, and not intense pain. Still, he never considered himself an advocate for the legalization of a federally classified Schedule I drug.

Then, a tragic diagnosis, his father’s aggressive brain cancer, presented an opportunity to share his learnings with, at the least, his loved ones. Cunningham dived deep into oncology study after study, researching ways to help his father beat the cancer that stole from the seasoned author even the ability to write a complete sentence.

It wasn’t until just weeks before his death that Cunningham’s father overcame the social stigma, acquiesced to his son, and signed up for a medical cannabis card. The crippling insomnia he’d suffered for months as a result of twice daily cancer treatments vanished on the first night; he slept soundly. But, the treatment came too late – and Cunningham wishes to this day that his father had been presented with CBD as a complementary treatment from day one.

In a recent Hart2020 campaign video, Cunningham implores viewers to, “Look at the evidence, look at it from a scientific standpoint.” And his supporters are right there with him, with one American commenting, “Thank you, thank you, thank YOU! You actually ‘get it.’ Looking forward to your Presidency, Mr. Hart.”

With a Cunningham Administration, Americans may finally see cannabis rescheduled on a federal level, gaining access to a drug critical to the health and wellbeing of millions.

About Hart Cunningham - #Hart2020

Hart Cunningham is running for the presidency in 2020 in the hopes of helping the world overcome struggles due to capitalism, unsustainable economic and environmental practices, and a lack of equality. After being a successful businessman for many years, Cunningham turned his attention to humanitarian work and to bringing awareness to these issues. Originally from the south, he’s made his roots in California and has a deep understanding of democratic and republican politics and ideals. True to his name, Hart Cunningham wants to bring the heart back into politics in America and believes that poverty and climate change must be solved for the greater good of our world. Volunteer or contribute to his campaign by visiting, http://hart2020.org.

Follow Hart Cunningham on Social Media

Twitter: https://www.twitter.com/HCfor2020
Facebook: https://www.facebook.com/HartCunningham2020

Hart Cunningham PR Team, Hart Cunningham 2020 Presidential Election, https://hart2020.org, 901-205-0167, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.